(Q43240884)

17 November 2017

title

Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells (English)

1 reference

17 November 2017

1 reference

A K Maiti

1

1 reference

17 November 2017

publication date

17 November 2009

1 reference

The Pharmacogenomics Journal

17 November 2017

published in

1 reference

17 November 2017

volume

10

1 reference

17 November 2017

issue

2

1 reference

17 November 2017

page(s)

94-104

1 reference

Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Choreography of oxidative damage repair in mammalian genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Therapeutic strategies by modulating oxygen stress in cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Repression of gene expression by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

A model for p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

A threshold concept for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Enhanced gamma-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Reduced DNA double strand breaks in chlorambucil resistant cells are related to high DNA-PKcs activity and low oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Enzyme immunoconjugates utilizing glucose oxidase and myeloperoxidase are cytotoxic to Candida tropicalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Role of reactive oxygen species in apoptosis: implications for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Influence of induced reactive oxygen species in p53-mediated cell fate decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Cyclic nucleotides and neuroblastoma differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Pak1 and PIX regulate contact inhibition during epithelial wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Sequential activation of phosphatidylinositol 3-kinase, beta Pix, Rac1, and Nox1 in growth factor-induced production of H2O2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Modulation of DNA-dependent protein kinase activity in chlorambucil-treated cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Oxidant mechanisms in neonatal hypoxia-ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

DNA adducts from chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

DNA-dependent protein kinase and checkpoint kinase 2 synergistically activate a latent population of p53 upon DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Reduction of cell cycle progression in human erythroid progenitor cells treated with tumour necrosis factor alpha occurs with reduced CDK6 and is partially reversed by CDK6 transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Is NF-kappaB2/p100 a direct activator of programmed cell death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

TRAF-3 interacts with p62 nucleoporin, a component of the nuclear pore central plug that binds classical NLS-containing import complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Molecular mechanisms of multidrug resistance in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized tria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

Pharmacokinetics of chlorambucil in patients with chronic lymphocytic leukaemia: comparison of different days, cycles and doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.49

21 January 2018

Identifiers

DOI

10.1038/TPJ.2009.49

1 reference

17 November 2017

1 reference